<?xml version="1.0" encoding="UTF-8"?>
<p>Two series of compounds exhibiting aminophenylbenzimidazole and benzimidazole like entities are patented by ViroPharma Inc. as HCV helicase inhibitors [
 <xref ref-type="bibr" rid="B62">62</xref>]. Vertex Pharmaceuticals Inc. accounted various aminothiadiazoliums which also exhibit anti-helicase activity but with lower efficacy [
 <xref ref-type="bibr" rid="B63">63</xref>]. Two derivatives of 2-arylbenzofuran isolated from Mori cortex radicis have shown potent inhibition against HCV NS3 helicase [
 <xref ref-type="bibr" rid="B62">62</xref>]. (Structures are cited in figure 
 <xref ref-type="fig" rid="F3">3</xref>).
</p>
